Referências Bibliográficas dos Ebooks

1 – Os Múltiplos Papéis da Fosfatidilcolina na Nutrição e na Saúde dos Animais

BARRIOS, Jose M.; LICHTENBERGER, Lenard M. Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology, v. 118, n. 6, p. 1179-1186, jun./2000.

EROS, G. et al. Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux. World Journal of Gastroenterology, Hungria, v. 12, n. 2, p. 271-279, jan./2006.

FURSE, Samuel; KROON, A. I. P. M. D. Phosphatidylcholine’s functions beyond that of a membrane brick. Molecular Membrane Biology,Utrecht, Países Baixos, v. 32, n. 4, p. 117-119, mai./2015.

LEWIS, E. D. et al. The Form of Choline in the Maternal Diet Affects Immune Development in Suckled Rat Offspring. The Journal of Nutrition, v. 146, n. 4, p. 823-830, abr./2016.

LI, Zhaoyu; VANCE, Dennis E.. Phosphatidylcholine and choline homeostasis: Thematic Review Series: Glycerolipids. Journal of lipid research, v. 49, n. 6, p. 1187-1194, jun./2008.

MAGAQUIAN, D. et al. Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress. Scientific Reports, v. 11, n. 1, nov./2021.

MENDES, Edmar Lacerda; BRITO, Ciro José. Carnitina, colina e fosfatidilcolina como nutrientes reguladores do metabolismo de lipídios e determinantes do desempenho esportivo. Educación Física y Deportes, v. 108, n. 12, p. 1, mai./2007.

NILSSON, Å.; DUAN, R.-D. Pancreatic and mucosal enzymes in choline phospholipid digestion. American Journal of
Physiology-Gastrointestinal and Liver Physiology, v. 316, n. 4, p. G425–G445, 1 abr. 2019.

PAOLETTI, L. et al. Role of Phosphatidylcholine during neuronal differentiation. IUBMB Life, trocar, v. 63, n. 9, p. 714-720, ago. /2011. SAEED, M. et al. Beneficial Impacts Of Choline In Animal And Human With Special Reference To Its Role Against Fatty Liver Syndrome. Journal of Experimental Biology and Agricultural Sciences, India, v. 5, n. 5, out./2017.

SHEA, Thomas B. Choline and phosphatidylcholine may maintain cognitive performance by multiple mechanisms. The American Journal of Clinical Nutrition, EUA, v. 110, n. 06, p. 1268-1269, dez./2019.

ZEISEL, Steven H. A Brief History of Choline. Annals of Nutrition and Metabolism, v. 61, n. 3, p. 254-258, jul./2012.

2 – Utilização dos Betaglucanos na alimentação: efeitos benéficos na saúde dos cães

AKRAMIENE, D. et al. Effects of beta-glucans on the immune system. Medicina, Kaunas, v. 43, n. 8, p. 597–606, Aug. 2007.

ALTUG, N.; YÜKSEK, N.; AGAOGLU, Z. T. Immunostimulatory Effects of Aloe vera and B-Glucan on Cellular and Humoral Immune Responses Following Vaccination with Polyvalent Vaccines in Dogs. Kafkas Univ Vet Fak Derg 16 (3): 405–412, 2010.DOI:10.9775/kvfd.2009.842.

BEYNEN, A.C., D.H.J. SARIS, P.M. PAAP, F. VAN ALTENA, E.A. VISSER, J. MIDDELKOOP, L. DE JONG AND M. STAATS. Dietary Beta-1,3/1,6-Glucans Reduce Clinical Signs of Canine Atopy. American Journal Animal and Veterinary Sciences 6 (4): 146–152, 2011.

BRUNETTO, M. A.; NOGUEIRA, S.; SÁ, C. F.; PEIXOTO, M.; VASCONCELLOS, R. S.; FERRAUDO, A. J.; CARCIOFI, A. C. Correspondência entre obesidade e hiperlipidemia em cães. Ciência Rural, Santa Maria, v.41, n.2, p.266–271, 2011.

CASE L. P.; CAREY D. P.; HIRAKAWA D. A. Elsevier Health Sciences. Development and Treatment of Obesity, cap. 28, p. 313–314, 2010.

CHAN, G. C.; CHAN, W. K.; SZE, D. M. The effects of B-glucan on human immune and cancer cells. J. Hematol. Oncol. 2, 25, 2009. doi:10.1186/1756-8722-2-25.

DAS, U. N. Is obesity an inflammatory condition? Nutrition, v. 17, n. 4, p. 953–963, 2001.

DIEZ, M.; NGUYEN, P. Obesity: epidemiology, pathophysiology and management of the obese dog. In: PIBOT, P. Encyclopedia of Canine Clinical Nutrition. France: Aniwa SAS. p. 2-57, 2006.

FANTUZZI, G. Adipose tissue, adipokines and inflammation. Journal of Allergy and Clinical Immunology, v. 115, n. 5, p. 911–919, 2005.

FERREIRA, C. S. Suplementação de betaglucano e variáveis metabólicas em cães obesos com resistência insulínica. 2016. 96 p. Tese (Doutorado em Ciências)-Universidade Estadual Paulista, Faculdade de Ciências Agrárias e Veterinárias, 2016.

HALADOVÁ, E.; MOJŽIŠOVÁ, J.; SMRCO, P.; ONDREJKOVÁ, A. VOJTEK, B.; PROKEŠ, M.; PETROVOVÁKAUR, E. Immunomodulatory effect of glucan on specific and nonspecific immunity after vaccination in puppies. Acta Veterinaria Hungarica 59 (1), pp. 77–86, 2011.

JERGENS, A. J. AND SIMPSON, K. W. Inflammatory bowel disease in veterinary medicine. Frontiers in Bioscience E4, 1404–1419, 2012.

MANCHO, C., SAINZ, A., GARCA-SANCHO, M., VILLAESCUSA, A., TESOURO, M. AND RODRIGUEZ-FRANCO, F. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease. J. Vet. Diagn. Invest. 22, 553–558, 2010.

MARCELL, T. J.; MCAULEY, K. A.; TRAUSTADÓTTIR, T.; REAVEN, P. D. Exercise training is not associated with improved levels of C reactive protein or adiponectin. Metabolism, v. 54, n. 4, p. 533–541, 2005.

NETO, G. B. P.; BRUNETTO, M. A.; SOUSA, M. G.; CARCIOFI, A. C.; CAMACHO, A. A. Effects of weight loss on the cardiac parameters of obese dogs. Brazilian Veterinary Research, v. 30, n. 2, p. 167–171, 2010.

PARIS, S.; CHAPAT, L.; PASIN, M.; LAMBIEL, M.; SHARROCK, T. E.; SHUKLA, R.; SIGOILLOT-CLAUDE, C.; BONNET, J. M.; POULET, H.; FREYBURGER, L.; DE LUCA, K. B-Glucan-Induced Trained Immunity in Dogs. Front. Immunol. 11:566893. doi: 10.3389/fimmu.2020.566893, 2020a.

PARIS S, CHAPAT L, MARTIN-CAGNON N, DURAND P-Y, PINEY L, CARIOU C, BERGAMO P, BONNET J-M, POULET H, FREYBURGER L AND DE LUCA K (2020b). B-Glucanas Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs. Front. Immunol. 11:564497. doi: 10.3389/fimmu.2020.564497

RAHAR, S. et al. Preparation, characterization, and biological properties of B-glucans. J Adv Pharm Technol Res. v. 2, n. 2, p. 94–103, 2011.

RYCHLIK, A.; NIERADKA, R.; KANDER, M.; NOWICKI, M.; WDOWIAK, M.; KOŁODZIEJSKA-SAWERSKA, A. The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs. Acta Veterinaria Hungarica 61 (3), pp. 297–308 ,2013.

SAAD, S. M. I. Probióticos e prebióticos: o estado da arte. Brazilian Journal of Pharmaceutical Sciences vol. 42, n. 1, jan./mar., 2006.

SANDVIK, A. et al. Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and orgam injuri in rats. Clinical and Experimental Immunology, Oxford, v. 148, n. 1, p. 168–177, Apr. 2007.

SIMPSON, K. W. AND JERGENS, A. E. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet. Clin. North. Am. Small Anim. Pract. 41, 381–398, 2011.

SONCK, E. et al. The effect of beta-glucans on porcine leukocytes. Veterinary Immunology and Immunopathology, Amsterdam, v. 135, n. 4, p. 199-207, 2010.

VETVICKA, et al. Phagocytosis of human blood leukocytes. A simple micromethod. Immunol. Lett. 5, 97–100, 1982.

VETVICKA, V.; OLIVEIRA, C. (1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs. British J Pharm Res, 4 (8): 981–991, 2014.

VIEIRA, M. A. Z.; BATTISTI, M. K. B.; SCHUTZ, A. S. B. Beta-glucanos como imunomodulador no tratamento da dermatite alérgica à saliva de pulga em cães. Arquivos Brasileiros de Medicina Veterinária FAG–Vol. 1, no 2, jul/dez 2018.

3 – Cúrcuma: Funções metabólicas e capacidade anti-inflamatória

AGGARWAL, B. B.; HARIKUMAR, K. B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol., v. 41, p. 40-59, 2009.

AHMED, R.; GOUDA, S.; MOUSA, S. Impact of Usage Curcuma Longa Extract on Experimental Canine Steroidal Hepatopathy: Clinical and Therapeutic Aspects. Advances in Animal and Veterinary Sciences, 2020. doi:10.17582/journal.aavs/2021/9.4.588.594

BASNET, P.; SKALKO-BASNET, N. Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment. Molecules, v. 16, n. 6, p. 4567-4598, 2011.

COLITTI, M.; GASPARDO, B.; DELLA PRIA, A.; ACAINI, C.; STEFANON, B. Transcriptome modification of white blood cells after dietary administration of curcumin and non-steroidal anti-inflammatory drug in osteoarthritic affected dogs. Veterinary Immunology and Immunopathology, v. 147, n. 3-4, p. 136-146, 2012. doi:10.1016/j.vetimm.2012.04.001

CAMPIGOTTO, G. et al. Dog food production using curcumin as antioxidant: effects of intake on animal growth, health and feed conservation. Arch Anim Nutr, 2020a. doi:10.1080/1745039X.2020.1769442

CAMPIGOTTO, G. et al. Intake of snacks containing curcumin stimulates erythropoiesis and antioxidant response in dogs. Comparative Clinical Pathology, 2020b. doi:10.1007/s00580-020-03125-9

COMBLAIN, F. et al. Review of dietary supplements for the management of osteoarthritis in dogs in studies from 2004 to 2014. J. Vet. Pharmacol. Therap., v. 39, p. 1-15, 2015. doi:10.1111/jvp.12251

CORBEE, R. J. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. Vet Med Sci., 2022. doi:10.1002/vms3.779

EL-BAHR, S. Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats. BMC Complement Altern Med., v. 13, p. 368, 2013.

FARINACCI, M.; COLITTI, M.; STEFANON, B. Modulation of ovine neutrophil function and apoptosis by standardized extracts of Echinacea angustifolia, Butea frondosa and Curcuma longa. Vet. Immunol. Immunopathol., v. 128, p. 366-373, 2009.

FOSSEY, S. L. et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer, v. 11, n. 112, 2011.

HATCHER, H. et al. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci., v. 65, p. 1631-1652, 2008.

HEAD, E. et al. A Combination Cocktail Improves Spatial Attention in a Canine Model of Human Aging and Alzheimer’s Disease. Journal of Alzheimer’s Disease, v. 32, p. 1029-1042, 2012.

HENROTIN, Y.; KURZ, B. Antioxidant to treat osteoarthritis: dream or reality? Curr. Drug Targets, v. 8, p. 347-357, 2007.

HEWLINGS, S. J.; KALMAN, D. S. Curcumin: A review of its’ effects on human health. Foods, v. 6, p. 92-98, 2017.

HOWELLS, L. M. et al. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Int. J. Cancer, v. 129, p. 476-486, 2011.

MANDAL, M.; JAISWAL, P.; MISHRA, A. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review. Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow 226002, U.P., India, 2020.

MARCHI, J. P. et al. Curcuma longa L., o açafrão da terra, e seus benefícios medicinais. Arq. Cienc. Saúde UNIPAR, Umuarama, v. 20, n. 3, p. 189-194, 2016.

MARTINEAU, A. S. et al. Curcumin antagonizes the effects of EPA and DHA supplementation on oxidative stress in dogs. The FASEB Journal, v. 28, n. 1_supplement, 2014.

SANTOS, M. M. B. et al. Avaliação das lesões locais de cães envenenados experimentalmente com Bothrops alternatus após diferentes tratamentos. Arquivos Brasileiros De Medicina Vet e Zootecnia, v. 55, p. 639-644, 2003.

SHAKIBAEI, M. et al. Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem. Pharmacol., v. 73, p. 1434-1445, 2007.

SREEJAYAN, N.; RAO, M. N. A. Free radical scavenging by curcuminoids. Arzneimittel Forschung – Drug Research, v. 46, p. 169-171, 1996.

TEI, M. et al. The Binding of Curcumin to Various Types of Canine Amyloid Proteins. J. Vet. Med. Sci., v. 74, n. 4, p. 481-483, 2012.

VENUGOPAL, M. P.; SUDHEER, A. R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol., v. 2, p. 105-125, 2007.